- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medrad signs UltraGuide
Interventional CT represents a strategic opportunity for Medrad. The company has signed its second distribution agreement in three months, this one with Lakewood, CO-based UltraGuide, for products addressing this market segment.Medrad, a U.S. subsidiary
Interventional CT represents a strategic opportunity for Medrad. The company has signed its second distribution agreement in three months, this one with Lakewood, CO-based UltraGuide, for products addressing this market segment.
Medrad, a U.S. subsidiary of Schering, agreed in January to begin distributing UltraGuide's CT-Guide in the U.S. and France. The visual guidance system designed for minimally invasive CT procedures will be marketed along with SimpliCT, a CT guidance device manufactured by NeoRad. A distribution agreement for SimpliCT was signed in November. Interventional guidance is a natural extension of Medrad's product lines, according to the company, which provides MRI surface coils and power injectors for contrast-enhanced studies.
Study Reaffirms Low Risk for csPCa with Biopsy Omission After Negative Prostate MRI
December 19th 2024In a new study involving nearly 600 biopsy-naïve men, researchers found that only 4 percent of those with negative prostate MRI had clinically significant prostate cancer after three years of active monitoring.
Study Examines Impact of Deep Learning on Fast MRI Protocols for Knee Pain
December 17th 2024Ten-minute and five-minute knee MRI exams with compressed sequences facilitated by deep learning offered nearly equivalent sensitivity and specificity as an 18-minute conventional MRI knee exam, according to research presented recently at the RSNA conference.
Can Radiomics Bolster Low-Dose CT Prognostic Assessment for High-Risk Lung Adenocarcinoma?
December 16th 2024A CT-based radiomic model offered over 10 percent higher specificity and positive predictive value for high-risk lung adenocarcinoma in comparison to a radiographic model, according to external validation testing in a recent study.
